ELDN - Eledon Pharmaceuticals, Inc.

QQQ $ 454.82 $ -0.84 (-0.19 %)

DIA $ 398.57 $ 6.05 (1.59 %)

SPY $ 530.36 $ 4.76 (0.91 %)

TLT $ 91.26 $ 0.61 (0.68 %)

GLD $ 225.37 $ -1.27 (-0.59 %)

Previous Close

$ 2.75

Open

$ 2.63

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.63 - $ 2.74

52 Week Range

$ 1.07 - $ 3.35

Volume

118,501

Average Volume

Market Cap

82.47M

Beta (5Y Monthly)

$ 0.26

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-28-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-30-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-11-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	03-24-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-14-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K
15	11-16-2020	09-30-2020	10-Q
16	08-14-2020	06-30-2020	10-Q
17	05-15-2020	03-31-2020	10-Q
18	03-17-2020	12-31-2019	10-K
19	11-13-2019	09-30-2019	10-Q
20	08-13-2019	06-30-2019	10-Q
21	05-14-2019	03-31-2019	10-Q
22	03-28-2019	12-31-2018	10-K
23	11-13-2018	09-30-2018	10-Q
24	08-07-2018	06-30-2018	10-Q
25	05-11-2018	03-31-2018	10-Q
26	04-02-2018	12-31-2017	10-K
27	11-08-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-03-2017	03-31-2017	10-Q
30	03-03-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-10-2016	12-31-2015	10-K
35	11-10-2015	09-30-2015	10-Q
36	08-12-2015	06-30-2015	10-Q
37	05-12-2015	03-31-2015	10-Q
38	03-26-2015	12-31-2014	10-K
39	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
05/17/2024 20:31:00

HC Wainwright & Co. Reiterates Buy on Eled...
05/10/2024 19:26:57

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $16 price ...

Eledon Pharma Q1 2024 GAAP EPS $(0.34) Bea...
05/09/2024 12:13:59

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.39)...

nano-cap-eledon-pharmaceuticals-investigational-drug-shows-safety-in-early-organ-transplant-study-analyst-boosts-forecast-on-increased-confidence

Nano-Cap Eledon Pharmaceuticals' Investiga...
05/07/2024 19:40:23

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and e...

HC Wainwright & Co. Maintains Buy on Eledo...
05/07/2024 14:16:19

HC Wainwright & Co. analyst Vernon Bernardino maintains Eledon Pharma (NASDAQ:ELDN) with a Buy and raises the price targ...

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
05/07/2024 12:06:20

Eledon Pharmaceuticals Announced A Private...
05/07/2024 11:23:50

Eledon Announces Clinical Progress With Te...
05/07/2024 11:21:38

First participant dosed in clinical trial at University of Chicago Medicine assessing the use of tegoprubart to prevent islet...

Watching Eledon Pharmaceuticals, Acumen Ph...
04/18/2024 15:41:59

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-are-poised-for-over-300-gains-say-analysts/

Eledon Pharma Q4 2023 GAAP EPS $(0.32) Bea...
03/28/2024 20:07:10

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.39)...

Eledon Pharmaceuticals Reports 12th Partic...
03/25/2024 20:58:05

HC Wainwright & Co. Reiterates Buy on Eled...
03/22/2024 10:35:26

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price ...

kidney-transplant-from-genetically-edited-pig-boston-patient-with-end-stage-renal-disease-becomes-first-to-receive

Kidney Transplant From Genetically Edited ...
03/21/2024 18:35:57

Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential t...

Eledon Pharmaceuticals Announces Use Of Te...
03/21/2024 14:31:59

Historic kidney xenotransplantation procedure conducted at Massachusetts General HospitalTegoprubart administration has now bee...

Eledon Pharmaceuticals Provides Guidance F...
01/04/2024 21:44:05

Anticipated 2024 Milestones: First half of 2024: Report updated interim clinical data from the ongoing Phase 1b trial of te...

Expert Ratings for Eledon Pharma
11/13/2023 15:00:19

HC Wainwright & Co. Reiterates Buy on Eled...
11/13/2023 12:47:24

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price ...

Eledon Pharma Q3 EPS $(0.35) Beats $(0.50)...
11/09/2023 21:52:00

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.50)...

Eledon Reports Updated Data From Ongoing P...
11/02/2023 13:22:42

Data from 11 participants demonstrates tegoprubart successfully prevented kidney transplant rejection and was generally safe an...

HC Wainwright & Co. Maintains Buy on Eledo...
10/24/2023 11:04:32

HC Wainwright & Co. analyst Vernon Bernardino maintains Eledon Pharma (NASDAQ:ELDN) with a Buy and lowers the price targ...